Lufeng Chen
About
In The Last Decade
Lufeng Chen
38 papers receiving 700 citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Health, Toxicology and Mutagenesis 178
- Biomedical Engineering 171
- Materials Chemistry 132
- Pollution 124
- Electrical and Electronic Engineering 106
Countries citing papers authored by Lufeng Chen
This map shows the geographic impact of Lufeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lufeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lufeng Chen more than expected).
Fields of papers citing papers by Lufeng Chen
This network shows the impact of papers produced by Lufeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lufeng Chen. The network helps show where Lufeng Chen may publish in the future.
Co-authorship network of co-authors of Lufeng Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Lufeng Chen. A scholar is included among the top collaborators of Lufeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lufeng Chen. Lufeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 14 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 17 | |
| 8 | 9 | |
| 9 | 15 | |
| 10 | 8 | |
| 11 | 26 | |
| 12 | 21 | |
| 13 | 18 | |
| 14 | 23 | |
| 15 | 10 | |
| 16 | 48 | |
| 17 | 14 | |
| 18 | The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib. | 1 |
| 19 | 24 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.